Current trends in producing low levels of caffeine in coffee berry and processed coffee powder

Food Reviews International

Volumn 25, Issue 3, 2009, Pages 175-197

  Kumar, Vinod ^a   Ravishankar, G A ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Caffeine; Coffea sp; Decaffeination; Health; N methyl transferase

Indexed keywords

BIOACTIVE COMPOUNDS; COFFEA SP; DECAFFEINATION; LATEST DEVELOPMENT; N-METHYL TRANSFERASE; NATURALLY OCCURRING; PHYSIOLOGICAL EFFECTS; SOLVENT-EXTRACTION PROCESS;

CAFFEINE; HEALTH; SOLVENT EXTRACTION;

COFFEE;

ANIMALIA; COFFEA;

EID: 70449463069     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559120802458099     Document Type: Article

References (146)

1. Charrier, A.; Berthaud, J. Variation de la teneur en caféine dans le genre Coffea. Café Cacao Thé. 1975, 19, 251-264.
2. Zheng, X.; Ye, C.; Kato, M.; Crozier, A.; Ashihara, H. Theacrine (1,3,7,9-tetramethyluric acid) synthesis in leaves of a Chinese tea, kucha (Camellia assanica var. kucha). Phytochem. 2002, 60, 129-134.
3. Hammerstone, J.F.; Romanczyk, L.J.; Aitken, W.M. Purine alkaloid distribution within Herrania and Theobroma. Phytochem. 1994, 35, 1237-1240.
4. Ogita, S.; Uefuji, H.; Morimoto, M.; Sano, H. Metabolic engineering of caffeine production. Plant. Biotech. 2005, 22, 461-468.
5. Ashihara, H.; Suzuki, T. Distribution and biosynthesis of caffeine in plants. Front. Biosci. 2004, 9, 1864-1876.
6. Frischknecht, P.M.; Ulmer-Dufek, J.; Baumann, T.W. Purine alkaloid formation in buds and developing leaflets of Coffea arabica: expression of an optimal defense strategy? Phytochem. 1986, 25, 613-616.
7. Nathanson, J.A. Caffeine and related methyl xanthines: possible naturally occurring pesticides. Science 1984, 226, 184-187.
8. Rizvi, S.J.H.; Mukerji, D.; Mathur, S.N. A new report on a possible source of natural herbicide. Indian J. Exp. Biol. 1980, 18, 777-778.
9. Buchanan, R.L.; Tice, G.; Marino, D. Caffeine inhibition of Ochratoxin A production. J. Food. Sci. 1981, 47, 319-321.
10. Prabhuji, S.K.; Srivastava, G.C.; Rizvi, S.J.H.; Mathur, S.N. 1,3,7-Trimethyl xanthine (caffeine), a new natural fish fungicide. Experientia. 1983, 39, 177-179.
11. Rizvi, S.J.H.; Rizvi, V.; Mukerjee, D.1,3,7-Trimethylxanthine, an allelochemical from seeds of Coffea arabica: some aspects of its mode of action as a natural herbicide. Plant Soil 1987, 98, 81-91.
12. Waller, G.R.; Kumari, D.; Friedman, J.; Friedman, N.; Chou, C.H. Caffeine autotoxicity in Coffea arabica L: In The Science of Allelopathy; Putnam, A.R.; Tang, C.-S.; Eds.: John Wiley & Sons: New York, 1986; 243-269.
13. Hollingsworth, J.W.; Armstrong Campbell, E. Caffeine as a repellent for slugs and snails. Nature 2002, 417, 915-916.
14. Biratu, T.; Omondi, C.; Hindorf, H. Caffeine content in relation to resistance of Coffea arabica L. to coffee berry disease (Colletotrichum coffeanum Noack). J. Plant Dis. Protec. 1996, 103, 15-19.
15. th International Scientific Colloquium on Coffee; ASIC Paipa: Colômbia, 1990; 733-744.
16. Mazzafera, P. Análises químicas em folhas de cafeeiros atacados por Atta spp. Rev. Agric. 1991, 66, 33-45.
17. Uefuji, H.; Tatsumi, Y.; Morimoto, M.; Kaothien-Nakayama, P.; Ogita, S.; Sano, H. Caffeine production in tobacco plants by simultaneous expression of three coffee N-methyltrasferases and its potential as a pest repellant. Plant Mol. Biol. 2005, 59, 221-227.
18. Weinberg, B.A.; Bealer, B.K. The world of caffeine: the science and culture of the world's most popular drug; New York: Routledge, 2001.
19. Daglia, M.; Racchi, M.; Papetti, A.; Lanni, C.; Govoni, S.; Gazzani, G. In vitro and ex vivo antihy- droxyl radical activity of green and roasted coffee. J. Agric. Food. Chem. 2004, 52 (6), 1700-1704.
20. Barone, J.J.; Roberts, H.R. Caffeine Consumption. Fd. Chem. Toxic. 1996, 34, 119-129.
21. Oser, B.L.; Ford, R.A.; Caffeine: an update. Drug Chem. Toxicol., 1981, 4, 311-329.
22. Kawachi, I.; Colditz, G.A.; Stone, C.B. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. British Heart Journal. 1994, 72, 269-275.
23. Garattini, S. Caffeine, coffee and health; Raven Press: New York, 1993.
24. Curatolo, P.W.; Robertson, D. The health consequences of caffeine. Ann. Intern. Med. 1983, 98, 641-653.
25. La Vecchia, C. Coffee and cancer epidemiology. In Caffeine, coffee and health, Gurattini, S. Ed.; Raven Press: Milan, 1993.
26. Hinds, T.S.; West, W.L.; Knight, E.M.; Harland, B.F. The effect of caffeine on pregnancy outcome variables. Nutrition Rev. 1996, 54, 203-207.
27. George, S.E.; Ramalakshmi, K; Mohan Rao, L.J. A perception on health benefits of coffee. Crit. Rev. Food Sci. Nutr. 2008, 48, 464-486.
28. http://www.ico.org/caffeine.asp.
29. Nehlig, A.; Debry, G. coffee and cancer: a review of human and animal data. World Rev. Nutr. Diet. 1996, 79, 185-221.
30. Folsom, A.R.; McKenzie, D.R.; Disgard, K.M.; Kushi, L.H.; Sellers, T.A. No association between caffeine intake and post menopausal cancer incidence in the Iowa women's health study. Am. J. Epidemol. 1993, 138, 308-383.
31. Tavani, A.; Pregnolato, A.; la Vecchia, C.; Favero, A.; Francesschi, S. Coffee consumption and the risk of breast cancer. Eur. J. cancer prevent. 1998, 7, 77-82.
32. World Health Organization International Agency for research on cancer (WHO/IARC). Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. In IARC Monograph in the evaluation of Carcinogenic risks to Humans; IARC: Lyon, France, 1991 51, 41-206.
33. Inoue, M.; Tajima, K.; Hirose, K. et al. Tea and coffee consumption and the risk of digestive tract cancers, data from a comparative case-referent study in Japan. Cancer Causes Contr. 1998, 9, 209-216.
34. Nishi, M.; Ohba, S.; Hirata, K.; Miyake, H. Dose-response relationship between coffee and the risk of pancreas cancer. Jpn. J. Oncol. 1996, 26, 42-48.
35. Giovannaucci, E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am. J. epidemol 1998, 147, 1043-1052.
36. Obana, H.; Nakamura, S.; Tanaka, T.Suppressive effects of coffee on the ROS responses induced by UV and chemical mutagens. Mut. Res. 1986, 175, 47-50.
37. Nagao, M.; Fujita, Y.; Wakbayashi, K.; Nukaya, H.; Kosuge, T.; Sugimura, T. Mutagens in coffee and other beverages Environ. Health. Perspect. 1986, 67, 89-91.
38. Nehlig, A.; Debry, G. Effects of coffee on the central nervous system. In editor. Coffee and health; Debry, G.; Ed.; London: Libbey, 1994; 157-249.
39. Nehlig, A.; Debry, G. Potential genotoxic mutagenic and antimutagenic effects of coffee: a review. Mut. Res. 1994, 317, 145-162.
40. Stadler, R.H.; Turesky, R.J.; Muller, O.; Markovic, J.; Leong Morgenthaler, P.M. The inhibitory effects of coffee on radical mediated oxidation and mutagenesity. Mut. Res. 1994, 308, 177-190.
41. Abraham, S.K. Inhibitory effects of coffee on the genotoxicity of carcinogens in mice. Mut. Res. 1991, 262, 109-114.
42. Stadler, R.H.; Richoz, J.; Turesky, R.J.; Welti, D.H.; Fay, L.B. Oxidation of caffeine and related methyl xanthines in ascorbate and polyphenol driven Fenton type oxidants Free. Rad. Res. 1995, 24, 225-240.
43. Sanchez-Gonzalez, I.; Jimenez-Escrig, A.; Saura-Calixto, F. In vitro antioxidant activity of coffees brewed using different procedures (Italian, espresso and filter) Food Chem. 2005, 90, 133-139.
44. Myers, M.G. Coffee and coronary heart disease. Arch. Intern. Medi. 1992, 152, 1767-1772.
45. Willett, W.C.; Stampfer, M.J.; Manson, J.E. et al Coffee consumption and coronary heart disease in women, a ten-year follow up. J. Am. Med. Assoc. 1996, 276, 458-462.
46. Sesso, H.D.; Gazino, J.M.; Buring, J.E.; Hennekens, C.H. Coffee and tea intake and the risk of myocardial infarction Am. J. Epidemol. 1999, 149, 162-167.
47. Greenland, S.A. meta analysis of coffee, myocardial infraction, and coronary death. Epidemiology. 1993, 4, 366-374.
48. Palmer, J.R.; Rosenberg, L.; Sowmya, R.; Shapiro, S. Coffee and consumption and myocardial infraction in women. Am. J. Epidemol. 1995, 141, 724-731.
49. Debry, G. Coffee and health, Gerard Debry (ed), Edition John Libbey, Eurotext, Paris, France, 1994,1-538.
50. Green, P.J.; Kirby, R.; Suls, J. The effects of caffeine on blood pressure and heart rate: a review. Ann. Behav. Med. 1996, 18, 201-216.
51. Thelle, D.S.; Heyden, S.; Fodor, J.G. Coffee and cholesterol in epidemiological and experimental studies. Artherosclerosis 1987, 67, 97-103.
52. Nygard, O.; Refsum, H.; Ueland, P.M.; Vollset, S. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland homocysteine study. Am. J. Clin. Nutr. 1998, 67, 263-270.
53. Oshaug, A.; Bugge, K.H.; Refsum, H. Diet: an independent determinant for plasma total homocysteine. A cross sectional study of Norwegian workers on platforms in the North Sea. Eur. J. Clin. Nutr. 1998, 52, 7-11.
54. Heaney, R.P.; Recker, R.R. Effects of nitrogen, phosphorous, and caffeine on calcium balance in women. J. Lab. Clin. Med. 1982, 99, 46-55.
55. Barger-Lux, M.J.; Heaney, R.P. Caffeine and the calcium economy revisited. Osteoporosis Int. 1995, 5, 97-102.
56. Heaney, R.P. Effects of caffeine on bone and calcium, Economy, International Life Sciences Institute (ILSI) North America Publishers: Washington DC, 1998.
57. Brent, R.L. A systematic evaluation of the reproductive risks of caffeine; International Life sciences Institute (ILSI) North America Publishers: Washington, DC, 1998.
58. Dumas, M.; Gouyon, J.B.; Tenebaum, D.; Michiels, Y.; Esousse, A.; Alison, M. Systemic determination of caffeine plasma concentrations at birth in preterm and full term infants. Dev. Pharmacol. Ther. 1982, 4, 182-186.
59. Ford, R.P.K.; Schluter, P.J.; Mitchell, E.A.; Taylor, B.J.; Scragg, R.; Stewart, A.W. Heavy caffeine intake in pregnancy and sudden infant death syndrome. New Zealand Cot Death Study Group. Arch. Dis. Childhood. 1998, 78, 9-13.
60. Rondo, P.H.C.; Rodrigues, L.C.; Tomkins, A.M. Coffee consumption and intrauterine growth retardation in Brazil. Eur. J. Clin. Nutr. 1996, 50, 705-709.
61. Diugosz, L.; Belanger, K.; Hellenbrand, K.; Holford, T.R.; Leaderer, B.; Bracken, M.B. Maternal caffeine consumption and spontaneous abortion: a prospective cohort study. Epidemology. 1996, 7, 250-255.
62. Wilcox, A.; Weinberg, C Baird. Caffeinated beverages and decreased fertility Lancet 1988, 2, 1453-1456.
63. Stanton, C.K.; Gray, R.H. Effects of caffeine consumption on delayed conception. Am. J. Epidemol. 1995, 2, 163-167.
64. Smith, A. Effects of caffeine on human behaviour; International Life Sciences Institute (ILSI) North America North America Publishers: Washington DC, 1998.
65. Kawachi, I.; Willet, W.C.; Colditz, G.A.; Stampfer, M.J.; Speizzer, F.E. A prospective study of coffee drinking and suicide in women. Arch. Intern. Med. 1996, 156, 521-525.
66. Mino, Y.; Yastuda, N.; Fujimura, T. Ohara, H. Caffeine consumption and depressive symptomatology among medical students. Jpn. J. alcohol. Drug. Depend. 1990, 25, 486-496.
67. Nilssen, O.; Forde, O.H. Seven-year longitudinal population study of change in gamma -GT: the Tromo study. Am. J. Epidemol. 1994, 139, 787-792.
68. Tanaka, K.; Tokunga, S.; Kono, S. et al Coffee consumption and decrease serum gamma glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int. J. Epidemol. 1998, 27, 438-443.
69. Stelzer, K.J.; Koh, W.J.; Kurtz, H.; Greer, B.E.; Griffin, T.W. Caffeine consumption is associated with decrease severe late toxicity after radiation to the pelvis Int. J. Radiat. Onco. Biol. Phys. 1994, 30, 411-417.
70. Heilmann, W. Decaffeination of Coffee. In Coffee recent Developments; Clarke, R.J.; Vitzthum, O.G.; Eds.; Blackwell Science Ltd: London, 2001; 108-124.
71. Lecos, C. The latest caffeine scorecard, Consumer Food and Drug Administration (FDA). Washington Food and Drug Administration. March 1984, 18(2),14-16.
72. Anonymous. Evaluation of caffeine safety, a scientific status summary by the Institute of food technologists' expert panel on food safety and nutrition, Food technology, Institute of food technologists, Chicago, 1987, 41 (6), 105-113.
73. Tavani, A.; Vecchia, C.L. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes and Control 2004, 15, 743-757.
74. Devasagayam, T.P.; Kamat, J.P.; Mohan, H.; Kesavan, P.C. Caffeine as an antioxidant, Inhibition of lipid peroxidation induced by reactive species. Biochimica et Biophysica Acta 1996, 1282, 63-70.
75. Shi, X.; Dalal, N.; Join, A. Antioxidant behaviour of caffeine: Efficient scavenging of hydroxyl radicals. Food Chemistry Toxicol. 1991, 29, 1-6.
76. th ed. Easton, PA: Mack Publishing Company. 1985, 1133-1135.
77. F.D.C. Reports Caffeine is effective as analgesic adjuvant in aspirin products. Health News Daily. 1993, 5 (69), 2.
78. Griffiths, R.R.; Mumford, G.K. Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans. In Handbook of experimental pharmacology, Vol. 118; Schuster, C.R.; Kuhar, M.J.; Ed.; Heidelberg: Springer, 1996: 315-341.
79. Griffiths, R.R.; Evans, S.M.; Heishman, S.J.; Preston, K.L.; Sannerud, C.A.; Wolf, B.; Woodson, P.P. Low-dose caffeine physical dependence in humans. J. Pharmacol. Exp. Ther. 1990, 255, 1123-1132.
80. Hughes, J.R.; Oliveto, A.H.; Bickel, W.K.; Higgins, S.T.; Badger, G.J. Caffeine self- administration and withdrawal: incidence, individual differences and interrelationships. Drug Alcohol Depend. 1993, 32, 239-246.
81. Richardson, N.J.; Rogers, P.J.; Elliman, N.A.; O'Dell, R.J. Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol. Biochem. Behav. 1995, 52, 313-320.
82. Silverman, K.; Evans, S.M.; Strain, E.C.; Griffiths, R.R. Withdrawal syndrome after the double-blind cessation of caffeine consumption. New Engl. J. Med. 1992, 327, 1109-1114.
83. Strain, E.C.; Griffiths, R.R. Caffeine dependence: fact or fiction? J. Roy. Soc. Med. 1995, 88, 437-440.
84. Strain, E.C.; Mumford, G.K.; Silverman, K.; Griffiths, R.R. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. JAMA. 1994, 272, 1043-1048.
85. Finn, I.B.; Holtzman, S.G. Tolerance to caffeine-induced stimulation of locomotor activity in rats. J. Pharmacol. Exp. Ther. 1986, 238, 542-546.
86. Holtzman, S.G. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine. Life Sci. 1983, 33, 779-787.
87. Carney, J.M. Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Brit. J. Pharmacol. 1982, 75, 451-454.
88. Carroll, M.E.; Hagen, E.W.; Asencio, M.; Brauer, L.H. Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects. Pharmacol. Biochem. Behav. 1989, 31, 927-932.
89. Sinton, C.M.; Petitjean, F. The influence of chronic caffeine administration on sleep parameters in the cat. Pharmacol. Biochem. Behav. 1989, 32, 459-462.
90. Vitiello, M.; Woods, S.C. Caffeine: preferential consumption by rats. Pharmacol. Biochem.Behav. 1977, 3, 147-149.
91. Levy, M.; Zylber-Katz, E. Caffeine metabolism and coffee attributed sleep disturbances. Clin. Pharmacol. Ther. 1983, 33, 770-775.
92. Schenk, S.; Worley, C.M.; McNamara, C.; Valadez, A. Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats. Psychopharmacol. 1996, 126, 17-23.
93. Worley, C.M.; Valadez, A.; Schenk, S. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine. Pharmacol. Biochem. Behav. 1994, 48, 217-221.
94. Nehlig, A.; Daval, J.L.; Boyet, S.; Vert, P. Comparative effects of acute and chronic adminis- tration of caffeine on local cerebral glucose utilization in the conscious rat. Eur. J. Pharmacol. 1986, 129, 93-103.
95. Nehlig, A.; Lucignani, G.; Kadekaro, M.; Porrino, L.J.; Sokoloff, L. Effects of acute administration of caffeine on local cerebral glucose utilization in the rat. Eur. J. Pharmacol. 1984, 101, 91-100.
96. Okada, M.; Kiryu, K.; Kawata, Y.; Mizuno, K.; Wada, K.; Tasaki, H.; Kaneko, S. Determina- tion of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 1997, 321, 181-188.
97. Okada, M.; Mizuno, K.; Kaneko, S. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 1996, 212, 53-56.
98. th ed.; New York: Pergamon Press, 1990; 619-630.
99. th ed.; American Pharmaceutical Association: Washington, DC, 1990; 230-241.
100. th Edition, United States Pharmacopeial Convention. Rockville, MD, 1998.
101. Ramalakshmi, K., Raghavan, B. Coffee: a perspective on processing and products. In: Hand- book of post harvest technology-Cereals, fruits, vegetables, tea, and spices. Ed: Chakravarty, Majumdar, Vijaya Raghavan, Ramaswamy, New York: Marcel Dekker Inc. 2003, pp. 697-739.
102. Ramalakshmi, K.; Raghavan, B. Caffeine in Coffee: Its Removal. Why and How? Crit Rev Food Sci Nutr. 1999, 39, 441-456.
103. Lack, E.; Seidlitz, H. Commercial scale decaffeination of coffee and tea using supercritical CO2 In Extraction of nature products using near critical solvents; King, M.B.; Bott, T.R.; Eds.; Blackie: Glasgow, 1993; 101-139.
104. Silvarolla, M.B.; Mazzafera, P.; Fazuoli, L.C. A naturally decaffeinated arabica coffee. Nature 2004, 429, 826
105. Srinivasan, C.S. Current status and future thrust areas of research on varietal improvement and horticultural aspects of coffee. J. Coffee. Res. 1996, 26 (1), 1-16.
106. Charrier, A. La structure génétique des caféiers spontanés es la region Malgache (Mascarocoffea). In Leurs relations avec les caféiers d'origine africaine (Eucoffea), No. 87; Mémoires ORSTOM: Paris, 1978; 141.
107. Clifford, M.N.; Williams, T.; Bridson, D. Chlorogenic acids and caffeine as possible taxo- nomic criteria in Coffea and Psilanthus. Phytochem. 1989, 28, 829-838.
108. Smith, R.F. A history of coffee. In Coffee -Botany, Biochemistry and Production of Beans and Beverage; Clifford, M.N.; Willson, K.C.; Eds; The AVI Publishing Company, Inc.: Westport, CT, 1985; 1-12.
109. Clifford, M.N.; Gibson, C.L.; Rakotomalala, J.J.; Cros, E.; Charrier, A. Caffeine from green beans of Mascarocoffea. Phytochem. 1991, 30, 4039-4040.
110. Santa Ram, A.; Indu, E.P.; Chandrashekar, A.; Ravishankar, G.A.; Ganesh, D. Identification of low caffeine coffees in some interspecific hybrids and their progenies. J. Plantation Crops 2005, 33 (2), 90-94.
111. Ashihara, H.; Crozier, A. Biosynthesis and metabolism of Caffeine and related purine alkaloids. Adv. Bot. Res. 1999, 30, 117-205.
112. Ashihara, H.; Crozier, A. Caffeine, a well known but litlle mentioned compound in plant science. Trends Plant Sci. 2001, 6, 407-413.
113. Suzuki, T.; Takahashi, E. Biosynthesis of caffeine by tea-leaf extracts: Enzymic formation of theo-bromine from 7-methylxanthine and of caffeine from theobromine. Biochem J. 1975, 146, 87-96.
114. Koshiishi, C.; Kato, Yama, S.; Crozier, A.; Ashihara, H. A new caffeine biosynthetic pathway in tea leaves: utilisation of adenosine released from the S-adenosyl-L-methionine cycle. FEBS lett. 2001, 499, 50-54.
115. 9- nucleoside hydrolase activity in Coffea arabica and the biosynthesis of caffeine. Phytochem. 1979, 18, 451-455.
116. Baumann, T.W.; Koets, R.; Morath, P. N- methyltransferase activities in suspension cultures of Coffea arabica L. Plant Cell Rep. 1983, 2, 33-35.
117. Waller, G.R.; MacVean, C.D.; Suzuki, T. High production of caffeine and related enzyme activities in callus cultures of Coffea arabica L. Plant Cell Rep. 1983, 2, 109-112.
118. Mazzafera, P.; Wingsle, G.; Olsson, O.; Sandberg, G. S-adenosyl-L-methionine, theobromine 1-N-methyltransferase, an enzyme catalyzing the synthesis of caffeine in coffee. Phytochem. 1994, 37, 1577-1584.
119. th International Scientific Colloquium on Coffee; ASIC: Kyoto, 1995, 599-605.
120. Waldhausser, S.S.M.; Kretschmar, J.A.; Baumann, T.W. N-methyltransferase activities in caffeine biosynthesis: biochemical characterization and time course during leaf development of Coffea arabica. Phytochem. 1997, 44, 853-859.
121. Waldhausser, S.S.M.; Gillies, F.M.; Crozier, A.; Baumann, T.W. Separation of the N-7 methyltransferase,the key enzyme in caffeine biosynthesis. Phytochem. 1997, 45, 1407-1414.
122. Kato, M.; Mizuno, K.; Fujimura, M.; Iwama, M.; Irie, A.; Crozier, A.; Ashihara, H. Purification and characterization of caffeine synthase from tea leaves. Plant Physiol. 1999, 120, 597-586.
123. Kato, M.; Mizuno, K.; Crozier, A.; Fujimura, T.; Ashihara, H. Caffeine synthase gene from tea leaves. Nature. 2000, 406, 956-957.
124. Ogawa, M.; Herai, Y.; Koizumi, N.; Kusano, T.; Sano, H. 7-methylxanthine methyltransferase of coffee plants. J. Biol. Chem. 2001, 276, 8213-8218.
125. Mizuno, K.; Kato, M.; Irino, F.; Yoneyma, N.; Fujimura, T.; Ashihara, H. The first committed step reaction of caffeine biosynthesis: 7-methylxanthosine synthase is closely homologous to caffeine synthases in coffee Coffea arabica L.). FEBS Lett. 2003, 547, 56-60.
126. Mizuno, K.; Okuda, A.; Kato, M.; Yoneyama, N.; Tanaka, H.; Ashihara, H.; Fujimora, T. Isolation of a new dual-functional caffeine synthase gene encoding an enzyme for the conversion of 7-methylxanthine to caffeine from coffee Coffea arabica L.). FEBS Lett. 2003, 534, 75-81.
127. Uefuji, H.; Ogita, S.; Yamaguchi, Y.; Koizumi, N.; Sano, H. Molecular cloning and functional characterization of three distinct N-methyltransferases involved in the caffeine biosynthetic pathway in coffee plants. Plant Physiol. 2003, 132, 372-380.
128. Wink, M. Compartmentation of secondary metabolites and xenobiotics in plant vacuoles. Adv. Bot. Res. 1997, 25, 141-169.
129. Kalberer, P. Breakdown of caffeine in leaves of Coffea arabica L. Nature 1965, 205, 597-598.
130. th International Scientific Colloquium on Coffee; ASIC: Kyoto, 1995; 606-615.
131. Mazzafera, P. Estudo sobre o papel da cafeína em plântulas de café (Coffea arabica L.) Rev. Bras. Bot. 1990, 13, 97-102.
132. Mazzafera, P.; Crozier, A.; Magalhaes, A.C.N. Caffeine metabolism in Coffea arabica and other species of coffee. Phytochem. 1991, 30, 3913-3916.
133. Ashihara, H.; Monteiro, A.M.; Moritz, T.; Gillies, F.M.; Crozier, A. Catabolism of caffeine and related purine alkaloids in leaves of Coffea arabica L. Planta. 1996, 198, 334-339.
134. Dash, S.S.; Gummadi, S.N. Catabolic pathways and biotechnological applications of microbial caffeine degradation. Biotech. Lett. 2006, 28, 1993-2002.
135. Schwimmer, S.; Kurtzman, R.H.; Heftmann, E. Caffeine metabolism by Penicillium roque- forti. Arch. Biochem. Biophy. 1971, 147, 109-113.
136. Hakil, M.; Voisinet, F.; Viniegra-Gonzalez, G.; Augur, C. Caffeine degradation in solid state fermentation by Aspergillus tamarii: effects of additional nitrogen sources. Process. Biochem. 1999, 35, 103-109.
137. Sauer, M.; Kappeli, O.; Fiechter, A. Comparison of the cytochrome P-450 containing monoox- ygenases originating from two different yeasts. Develop. Biochem. 1982, 23, 452-457.
138. Komeda, A.Y.; Yamada, H. Microbial production of theobromine from caffeine. Biosci. Biotech. Biochem. 1993, 57, 1286-1289.
139. Hakil, M.; Denis, S.; Viniegra-Gonzalez, G. Augur, C. Degradation and product analysis of caffeine and related dimethylxanthines by filamentous fungi. Enz. Microb. Tech. 1998, 22, 355-359.
140. Sarath Babu, V.R.; Patra, S.; Thakur, M.S.; Karanth, N.G.; Varadaraj, M.C. Degradation of caffeine by Pseudomonas alcaligenes CFR 1708. Enzyme Microb. Tech. 2005, 37, 617-624.
141. Ogita, S.; Uefuji, H.; Yamaguchi, Y.; Koizumi, N.; Sano, H. RNA interference: producing decaffeinated coffee plants. Nature 2003, 423, 823.
142. Ogita, S.; Uefuji, H.; Morimoto, M.; Sano, H. Application of RNAi to confirm theobromine as the major intermediate for caffeine biosynthesis in coffee plants with potential for construction of decaffeinated varieties. Plant. Mol. Biol. 2004, 54, 931-941.
143. Kumar, V.; Satyanarayana, K.V.; Indu, E.P.; Sarala Itty, S.; Giridhar, P.; Chandrashekar, A.; Ravishankar, G.A. Stable transformation and direct regeneration in Coffea canephora by Agro- bacterium rhizogenes mediated transformation without hairy root phenotype. Plant Cell Rep. 2006, 25, 214-222.
144. Kumar, V.; Satyanarayana, K.V.; Sarala Itty, S.; Giridhar, P.; Chandrashekar, A.; Ravishankar, G.A. Post transcriptional gene silencing for down regulating caffeine biosynthesis in Coffea cane- phora Pex Fr. In Proceedings of 20th International Conference on Coffee Science (ASIC), Oct 11- 15, The Association Scientifique Internationale pour le Café, Bangalore, India, 2004; 769-774.
145. Sunilkumar, G.; Campbell, L.M.; Puckhaber, L; Rathore K.S. Engineering cottonseed for use in human nutrition by tissue-specific reduction of toxic gossypol. Proceedings of the National Academy of Sciences, USA 2006, 103, 18054-18059.
146. Jaffe, G. Regulating transgenic crops: a comparative analysis of different regulatory processes. Transgenic Res. 2004, 13, 5-19.